Marianne Lantz

414 total citations
12 papers, 332 citations indexed

About

Marianne Lantz is a scholar working on Immunology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marianne Lantz has authored 12 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marianne Lantz's work include Renal Transplantation Outcomes and Treatments (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Immunotherapy and Immune Responses (4 papers). Marianne Lantz is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Immunotherapy and Immune Responses (4 papers). Marianne Lantz collaborates with scholars based in United States. Marianne Lantz's co-authors include Flavio Vincenti, Jytte L. Birnbaum, Marvin R. Garovoy, Susan Light, Diane R. Mould, Leslie Z. Benet, J Hakimi, Keith Nieforth, Dolly A. Parasrampuria and Daniel G. Pace and has published in prestigious journals such as Journal of Biological Chemistry, Pharmaceutical Research and Transplantation.

In The Last Decade

Marianne Lantz

12 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marianne Lantz United States	9	166	92	83	78	68	12	332
Jean-Paul Soulillou France	6	192 1.2×	181 2.0×	131 1.6×	76 1.0×	39 0.6×	7	439
Dominique Masson France	12	156 0.9×	215 2.3×	82 1.0×	53 0.7×	51 0.8×	49	470
N. A. Anderson United Kingdom	7	80 0.5×	94 1.0×	77 0.9×	27 0.3×	18 0.3×	11	392
W.J. Burlingham United States	11	110 0.7×	161 1.8×	115 1.4×	26 0.3×	20 0.3×	17	321
William J. Burlingham United States	8	86 0.5×	248 2.7×	82 1.0×	48 0.6×	23 0.3×	10	413
Constanze Schoenemann Germany	9	228 1.4×	165 1.8×	192 2.3×	60 0.8×	52 0.8×	17	453
Rubin Rh United States	10	49 0.3×	80 0.9×	43 0.5×	38 0.5×	27 0.4×	24	314
Gretchen N. de Graav Netherlands	12	285 1.7×	292 3.2×	105 1.3×	21 0.3×	25 0.4×	19	477
J.J. Cornelissen Netherlands	12	40 0.2×	222 2.4×	41 0.5×	93 1.2×	196 2.9×	32	657
Alexandre Dupont France	6	429 2.6×	326 3.5×	210 2.5×	45 0.6×	36 0.5×	8	610

Countries citing papers authored by Marianne Lantz

Since Specialization

Citations

This map shows the geographic impact of Marianne Lantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Lantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Lantz more than expected).

Fields of papers citing papers by Marianne Lantz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne Lantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Lantz. The network helps show where Marianne Lantz may publish in the future.

Co-authorship network of co-authors of Marianne Lantz

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne Lantz. A scholar is included among the top collaborators of Marianne Lantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne Lantz. Marianne Lantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Vincenti, Flavio, Daniel G. Pace, Jytte L. Birnbaum, & Marianne Lantz. (2003). Pharmacokinetic and Pharmacodynamic Studies of One or Two Doses of Daclizumab in Renal Transplantation. American Journal of Transplantation. 3(1). 50–52. 45 indexed citations

2.

Posselt, Andrew M., Flavio Vincenti, Melanie Bedolli, et al.. (2003). CD69 EXPRESSION ON PERIPHERAL CD8 T CELLS CORRELATES WITH ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS. Transplantation. 76(1). 190–195. 40 indexed citations

3.

Murayama, Nobuo, et al.. (2003). The functional change of P‐glycoprotein on lymphocytes under induction conditions as a function of MDRL polymorphisms. Clinical Pharmacology & Therapeutics. 73(2). 5 indexed citations

4.

Parasrampuria, Dolly A., Marianne Lantz, Jytte L. Birnbaum, Flavio Vincenti, & Leslie Z. Benet. (2002). Effect of Calcineurin Inhibitor Therapy on P‐gp Expression and Function in Lymphocytes of Renal Transplant Patients: A Preliminary Evaluation. The Journal of Clinical Pharmacology. 42(3). 304–311. 20 indexed citations

5.

Parasrampuria, Dolly A., Marianne Lantz, & Leslie Z. Benet. (2001). A Human Lymphocyte Based Ex Vivo Assay to Study the Effect of Drugs on P-glycoprotein (p-Gp) Function1. Pharmaceutical Research. 18(1). 39–44. 28 indexed citations

6.

Vincenti, Flavio, Marianne Lantz, Jytte L. Birnbaum, et al.. (1997). A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1. Transplantation. 63(1). 33–38. 118 indexed citations

7.

Lantz, Marianne, et al.. (1996). In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.. PubMed. 28(2). 915–6. 7 indexed citations

8.

Aweeka, Francesca, Thomayant Prueksaritanont, Stephen J. Tomlanovich, et al.. (1995). Immunopharmacodynamic Studies of Cyclosporine in Patients Awaiting Renal Transplantation. The Journal of Clinical Pharmacology. 35(10). 967–973. 6 indexed citations

9.

Huey, Bing, G M Lui, David G. Hwang, et al.. (1994). Suppression of interferon-γ induction of MHC class II and ICAM-1 by a 26-base oligonucleotide composed of deoxyguanosine and deoxythymidine. Transplant Immunology. 2(4). 285–292. 8 indexed citations

10.

Ramanathan, Murali, et al.. (1994). Characterization of the oligodeoxynucleotide-mediated inhibition of interferon-gamma-induced major histocompatibility complex class I and intercellular adhesion molecule-1.. Journal of Biological Chemistry. 269(40). 24564–24574. 29 indexed citations

11.

Ramanathan, Murali, Marianne Lantz, Roderick D. MacGregor, et al.. (1994). INHIBITION OF INTERFERON-γ-INDUCED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I EXPRESSION BY CERTAIN OLIGODEOXYNUCLEOTIDES. Transplantation. 57(4). 612–615. 13 indexed citations

12.

Ramanathan, Murali, Marianne Lantz, Roderick D. MacGregor, et al.. (1994). INHIBITION OF INTERFERON-γ-INDUCED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I EXPRESSION BY CERTAIN OLIGODEOXYNUCLEOTIDES. Transplantation. 57(4). 612–615. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact